NCIt definition : A fully human monoclonal agonist antibody directed against the extracellular domain
of human TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptor
2 (TR-2) with potential antineoplastic activity. Conatumumab mimics the activity of
native TRAIL, binding to and activating TR-2, thereby activating caspase cascades
and inducing tumor cell apoptosis. TR-2 is expressed by a variety of solid tumors
and cancers of hematopoietic origin.;
UNII : 1P48L61KM0;
CAS number : 896731-82-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 896731-82-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;